These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14717227)

  • 1. The relationship between serum VEGF concentration and prognosis of lung cancer.
    Park SH; Lee SS
    Korean J Intern Med; 2003 Dec; 18(4):207-11. PubMed ID: 14717227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.
    Akın Kabalak P; Çiledağ A; Demir N; Çelik G; Yüksel C; Köycü G; Gökmen Öztuna D; Taner A; Kaya A; Kutlay H; Numanoğlu N; Savaş İ
    Tuberk Toraks; 2015 Jun; 63(2):71-7. PubMed ID: 26167963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer.
    Suwinski R; Giglok M; Galwas-Kliber K; Idasiak A; Jochymek B; Deja R; Maslyk B; Mrochem-Kwarciak J; Butkiewicz D
    BMC Cancer; 2019 May; 19(1):427. PubMed ID: 31068179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evaluation to relationship between serum vascular endothelial growth factor (VEGF) level, metastases and other tumor markers in patients with lung cancer].
    Sağlam DA; Ursavaş A; Karadağ M; Yilmaztepe Oral A; Coşkun F; Gözü RO
    Tuberk Toraks; 2008; 56(1):50-5. PubMed ID: 18330755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.
    Shimanuki Y; Takahashi K; Cui R; Hori S; Takahashi F; Miyamoto H; Fukurchi Y
    Lung; 2005; 183(1):29-42. PubMed ID: 15793665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients.
    Kaya A; Ciledag A; Gulbay BE; Poyraz BM; Celik G; Sen E; Savas H; Savas I
    Respir Med; 2004 Jul; 98(7):632-6. PubMed ID: 15250229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.
    Song XY; Zhou SJ; Xiao N; Li YS; Zhen DZ; Su CY; Liu ZD
    Asian Pac J Cancer Prev; 2013; 14(8):4765-8. PubMed ID: 24083740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cripto-1 as a clinical marker for lung cancer.
    Xu CH; Cao L; Wei Y; Yu LK
    Int J Biol Markers; 2015 Nov; 30(4):e369-73. PubMed ID: 26109366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.
    Ustuner Z; Saip P; Yasasever V; Vural B; Yazar A; Bal C; Ozturk B; Ozbek U; Topuz E
    Med Oncol; 2008; 25(4):394-9. PubMed ID: 18317954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The estimation of serum concentration of vascular endothelial growth factor in patients with non-small cell lung cancer].
    Kopczyńska E; Dancewicz M; Kowalewski J; Kardymowicz H; Tyrakowski T
    Pol Merkur Lekarski; 2007 Jun; 22(132):536-8. PubMed ID: 17874624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy.
    Naumnik W; Nilklińska W; Ossolińska M; Chyczewska E
    Folia Histochem Cytobiol; 2009; 47(4):703-9. PubMed ID: 20430742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancers.
    Coelho AL; Araújo AM; Gomes MP; Catarino RJ; Andrade EB; Lopes AM; Medeiros RM
    Future Oncol; 2015; 11(24):3233-42. PubMed ID: 26562248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer.
    Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Ohta Y; Watanabe G
    Chest; 2004 Aug; 126(2):342-6. PubMed ID: 15302715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor (VEGF) serum levels are associated with survival in early stages of lung cancer patients.
    Carrillo-de Santa Pau E; Carrillo Arias F; Caso Pelaez E; Muguruza Trueba I; Sánchez Hernández I; Muñoz Molina GM; Moreno Balsalobre R; Sacristán López S; Gómez-Pinillos A; Toledo Lobo Mdel V
    Cancer Invest; 2010 May; 28(4):393-8. PubMed ID: 19968501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
    Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
    Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer.
    Matsuyama W; Hashiguchi T; Mizoguchi A; Iwami F; Kawabata M; Arimura K; Osame M
    Chest; 2000 Oct; 118(4):948-51. PubMed ID: 11035661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the serum intercellular adhesion molecule-1 level and the prognosis of the disease in lung cancer.
    Shin HS; Jung CH; Park HD; Lee SS
    Korean J Intern Med; 2004 Mar; 19(1):48-52. PubMed ID: 15053044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of microwave ablation or its combination with whole-body chemotherapy on serum vascular endothelial growth factor levels in patients with stage IIIB/IV NSCLC.
    Sun YH; Song PY; Guo Y; Pang M; He WN; Zhang WH; Sheng LJ
    Genet Mol Res; 2015 Aug; 14(3):10015-25. PubMed ID: 26345938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.